Illumina INC:1107104 [25-003044]
Ended Awarded Last action
- Contract number
- 75N92E25F50005
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Human Genome Research Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $217,194
Award facts
- Contract value 100% obligated
- $217,193.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $217,194 |
About this award
Illumina, Inc. has been awarded a delivery order valued at $217,193.76 by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health. This firm fixed-price delivery order, issued on July 17, 2025, with an ultimate completion date of May 21, 2026, will be performed at Illumina's facility in San Diego, California. The contract carries no set-aside designation, reflecting Illumina's specialized capabilities in genomic sequencing technologies. As a leading biotechnology company, Illumina will deliver advanced sequencing systems, reagents, consumables, and related services to support the NHGRI's research initiatives in genetic analysis and genome exploration.
This delivery order represents a continuation of Illumina's established partnership with federal agencies focused on genomic research and scientific advancement. The company's comprehensive portfolio of DNA and RNA sequencing platforms, including instruments such as NextSeq and NovaSeq systems, along with specialized reagent kits and bioinformatics software, directly supports the NHGRI's mission to advance human genome research. Illumina's track record of providing sophisticated genomic sequencing technologies across multiple federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and the Department of Agriculture, demonstrates the company's critical role in enabling cutting-edge biomedical and genetic research across the federal government.
Quick answers
Who was awarded contract 75N92E25F50005?
75N92E25F50005 was awarded to Illumina, Inc. by National Human Genome Research Institute (National Institutes of Health) on July 17, 2025.
How much is contract 75N92E25F50005 worth?
The government has obligated $217,194 on 75N92E25F50005.
Is contract 75N92E25F50005 an order under another contract?
Yes. 75N92E25F50005 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N92E25F50005 competed?
The extent of competition for 75N92E25F50005 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award